Encompass Health Co. (NYSE:EHC) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC increased its position in shares of Encompass Health Co. (NYSE:EHC) by 1.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,673,610 shares of the company’s stock after buying an additional 20,547 shares during the quarter. Geode Capital Management LLC’s holdings in Encompass Health were worth $161,781,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in EHC. Vestcor Inc lifted its holdings in shares of Encompass Health by 173.6% in the third quarter. Vestcor Inc now owns 57,879 shares of the company’s stock valued at $5,593,000 after buying an additional 36,721 shares during the period. M&T Bank Corp lifted its holdings in Encompass Health by 26.7% in the 3rd quarter. M&T Bank Corp now owns 3,910 shares of the company’s stock valued at $378,000 after acquiring an additional 823 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Encompass Health during the 3rd quarter valued at about $939,000. XTX Topco Ltd raised its holdings in shares of Encompass Health by 91.9% in the 3rd quarter. XTX Topco Ltd now owns 19,193 shares of the company’s stock worth $1,855,000 after purchasing an additional 9,191 shares in the last quarter. Finally, EP Wealth Advisors LLC acquired a new stake in Encompass Health during the third quarter valued at approximately $308,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on EHC. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, UBS Group boosted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Down 0.5 %

Encompass Health stock opened at $98.19 on Monday. Encompass Health Co. has a one year low of $65.33 and a one year high of $104.55. The company’s fifty day moving average price is $99.35 and its two-hundred day moving average price is $92.61. The company has a market capitalization of $9.89 billion, a price-to-earnings ratio of 23.72, a PEG ratio of 1.34 and a beta of 0.86. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same period last year, the business earned $0.86 EPS. On average, analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.